The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor mutational burden assessed by a targeted NGS assay to predict clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
 
Sacha Rothschild
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Serono (Inst)
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche Pharma AG
 
Ilaria Alborelli
No Relationships to Disclose
 
Katharina Leonards
No Relationships to Disclose
 
Laura P Leuenberger
No Relationships to Disclose
 
Spasenija Savic Prince
Honoraria - MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Kirsten D Mertz
No Relationships to Disclose
 
Severin Poechtrager
No Relationships to Disclose
 
Alfred Zippelius
No Relationships to Disclose
 
Heinz Philipp Laubli
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Jasmin Haegele
Employment - Novartis Institutes for BioMedical Research
 
Markus Tolnay
No Relationships to Disclose
 
Lukas Bubendorf
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Research Funding - MSD Oncology; Roche
 
Luca Quagliata
Employment - Thermo Fisher Scientific
 
Philip Jermann
Employment - Thermo Fisher Scientific
Research Funding - Bristol-Myers Squibb (Inst)